Selecting implementation strategies to improve implementation of integrated PrEP for pregnant and postpartum populations in Kenya: a sequential explanatory mixed methods analysis.

HIV infections/prevention and control Humans Nominal group technique Pregnancy and postpartum Strategy prioritization

Journal

Implementation science communications
ISSN: 2662-2211
Titre abrégé: Implement Sci Commun
Pays: England
ID NLM: 101764360

Informations de publication

Date de publication:
14 Aug 2023
Historique:
received: 16 09 2022
accepted: 29 07 2023
medline: 15 8 2023
pubmed: 15 8 2023
entrez: 14 8 2023
Statut: epublish

Résumé

There is a higher risk for HIV acquisition during pregnancy and postpartum. Pre-exposure prophylaxis (PrEP) is recommended during this period for those at high risk of infection; integrated delivery in maternal and child health (MCH) clinics is feasible and acceptable but requires implementation optimization. The PrEP in Pregnancy, Accelerating Reach and Efficiency study (PrEPARE; NCT04712994) engaged stakeholders to prioritize determinants of PrEP delivery (using Likert scores) and prioritize PrEP delivery implementation strategies. Using a sequential explanatory mixed methods design, we conducted quantitative surveys with healthcare workers at 55 facilities in Western Kenya and a stakeholder workshop (including nurses, pharmacists, counselors, and county and national policymakers), yielding visual plots of stakeholders' perceived feasibility and effectiveness of the strategies. A stepwise elimination process was used to identify seven strategies for empirical testing. Facilitator debriefing reports from the workshop were used to qualitatively assess the decision-making process. Among 146 healthcare workers, the strongest reported barriers to PrEP delivery were insufficient providers and inadequate training, insufficient space, and high volume of patients. Sixteen strategies were assessed, 14 of which were included in the final analysis. Among rankings from 182 healthcare workers and 44 PrEP policymakers and implementers, seven strategies were eliminated based on low post-workshop ranking scores (bottom 50th percentile) or being perceived as low feasibility or low effectiveness for at least 50% of the workshop groups. The top seven strategies included delivering PrEP within MCH clinics instead of pharmacies, fast-tracking PrEP clients to reduce waiting time, delivering PrEP-related health talks in waiting bays, task shifting PrEP counseling, task shifting PrEP risk assessments, training different providers to deliver PrEP, and retraining providers on PrEP delivery. All top seven ranked strategies were grouped into bundles for subsequent testing. Facilitator debriefing reports generally aligned with rankings but noted how stakeholders' decision-making changed when considering the impact of strategies on facility staff and non-PrEP clients. The most impactful barriers to integrated PrEP delivery in MCH clinics were insufficient staffing and space. Implementation strategies prioritized through multiple methods of stakeholder input focused on co-location of services and increasing clinic efficiency. Future testing of these stakeholder-prioritized strategy bundles will be conducted to assess the effectiveness and implementation outcomes.

Sections du résumé

BACKGROUND BACKGROUND
There is a higher risk for HIV acquisition during pregnancy and postpartum. Pre-exposure prophylaxis (PrEP) is recommended during this period for those at high risk of infection; integrated delivery in maternal and child health (MCH) clinics is feasible and acceptable but requires implementation optimization.
METHODS METHODS
The PrEP in Pregnancy, Accelerating Reach and Efficiency study (PrEPARE; NCT04712994) engaged stakeholders to prioritize determinants of PrEP delivery (using Likert scores) and prioritize PrEP delivery implementation strategies. Using a sequential explanatory mixed methods design, we conducted quantitative surveys with healthcare workers at 55 facilities in Western Kenya and a stakeholder workshop (including nurses, pharmacists, counselors, and county and national policymakers), yielding visual plots of stakeholders' perceived feasibility and effectiveness of the strategies. A stepwise elimination process was used to identify seven strategies for empirical testing. Facilitator debriefing reports from the workshop were used to qualitatively assess the decision-making process.
RESULTS RESULTS
Among 146 healthcare workers, the strongest reported barriers to PrEP delivery were insufficient providers and inadequate training, insufficient space, and high volume of patients. Sixteen strategies were assessed, 14 of which were included in the final analysis. Among rankings from 182 healthcare workers and 44 PrEP policymakers and implementers, seven strategies were eliminated based on low post-workshop ranking scores (bottom 50th percentile) or being perceived as low feasibility or low effectiveness for at least 50% of the workshop groups. The top seven strategies included delivering PrEP within MCH clinics instead of pharmacies, fast-tracking PrEP clients to reduce waiting time, delivering PrEP-related health talks in waiting bays, task shifting PrEP counseling, task shifting PrEP risk assessments, training different providers to deliver PrEP, and retraining providers on PrEP delivery. All top seven ranked strategies were grouped into bundles for subsequent testing. Facilitator debriefing reports generally aligned with rankings but noted how stakeholders' decision-making changed when considering the impact of strategies on facility staff and non-PrEP clients.
CONCLUSIONS CONCLUSIONS
The most impactful barriers to integrated PrEP delivery in MCH clinics were insufficient staffing and space. Implementation strategies prioritized through multiple methods of stakeholder input focused on co-location of services and increasing clinic efficiency. Future testing of these stakeholder-prioritized strategy bundles will be conducted to assess the effectiveness and implementation outcomes.

Identifiants

pubmed: 37580795
doi: 10.1186/s43058-023-00481-9
pii: 10.1186/s43058-023-00481-9
pmc: PMC10424426
doi:

Types de publication

Journal Article

Langues

eng

Pagination

93

Subventions

Organisme : NIMH NIH HHS
ID : K01 MH121124
Pays : United States
Organisme : NIH HHS
ID : R01 HD094630-03S1
Pays : United States
Organisme : NIH HHS
ID : K01MH121124
Pays : United States

Informations de copyright

© 2023. BioMed Central Ltd.

Références

AIDS Care. 2022 Mar;34(3):363-370
pubmed: 34543077
Implement Sci. 2021 Jul 6;16(1):69
pubmed: 34229706
Lancet HIV. 2020 Jan;7(1):e38-e48
pubmed: 31813837
AIDS. 2019 Jul 15;33(9):1501-1510
pubmed: 30932957
J Infect Dis. 2018 Jun 5;218(1):16-25
pubmed: 29514254
AIDS Behav. 2019 Aug;23(8):2185-2189
pubmed: 30666522
J Clin Epidemiol. 1993 Dec;46(12):1417-32
pubmed: 8263569
Health Aff (Millwood). 2016 Sep 1;35(9):1716-24
pubmed: 27605655
Br J Community Nurs. 2004 Mar;9(3):110-4
pubmed: 15028996
J Acquir Immune Defic Syndr. 2012 Apr 1;59(4):417-25
pubmed: 22193774
Int J Qual Health Care. 2005 Jun;17(3):187-91
pubmed: 15872026
J Infect Dis. 2017 Dec 19;216(12):1561-1568
pubmed: 29040666
N Engl J Med. 2012 Aug 2;367(5):399-410
pubmed: 22784037
J Contin Educ Health Prof. 2006 Winter;26(1):13-24
pubmed: 16557505
Implement Sci. 2015 Feb 12;10:21
pubmed: 25889199
Lancet HIV. 2020 Aug;7(8):e582-e592
pubmed: 32763221
Implement Sci. 2017 Aug 29;12(1):108
pubmed: 28851459
BMC Med Res Methodol. 2013 Sep 18;13:117
pubmed: 24047204
Spine (Phila Pa 1976). 2000 Dec 15;25(24):3186-91
pubmed: 11124735
J Infect Dis. 2009 Sep 1;200(5):667-9
pubmed: 19627246
J Acquir Immune Defic Syndr. 2018 Dec 15;79(5):590-595
pubmed: 30204720
J Int AIDS Soc. 2014 Mar 05;17:18808
pubmed: 24629842
Lancet Infect Dis. 2013 Jan;13(1):65-76
pubmed: 23257232
J Int AIDS Soc. 2020 Jan;23(1):e25426
pubmed: 31912985
Implement Sci. 2022 Oct 29;17(1):75
pubmed: 36309746
J Acquir Immune Defic Syndr. 2022 Jan 1;89(1):34-39
pubmed: 34560769
Hum Resour Health. 2010 Mar 31;8:8
pubmed: 20356363
J Int AIDS Soc. 2015 Jul 20;18(4 Suppl 3):20227
pubmed: 26198350
Sex Transm Dis. 2021 Oct 1;48(10):766-772
pubmed: 33859147
Implement Sci. 2009 Aug 07;4:50
pubmed: 19664226
PLoS Med. 2014 Feb 25;11(2):e1001608
pubmed: 24586123
BMJ Open. 2019 Mar 7;9(3):e025122
pubmed: 30850409
PLoS Med. 2012;9(5):e1001217
pubmed: 22615543
PLoS One. 2019 Jun 21;14(6):e0218556
pubmed: 31226165
Rev Gaucha Enferm. 2018 Jul 02;39:e20170164
pubmed: 29995073
J Int AIDS Soc. 2019 Sep;22(9):e25378
pubmed: 31498563
Implement Sci Commun. 2023 Jul 12;4(1):76
pubmed: 37438779
Fam Pract. 1993 Mar;10(1):76-81
pubmed: 8477899
Am J Public Health. 1999 Sep;89(9):1322-7
pubmed: 10474547
Eval Program Plann. 2017 Feb;60:166-175
pubmed: 27780609
Saudi J Anaesth. 2019 Apr;13(Suppl 1):S31-S34
pubmed: 30930717
Implement Sci. 2014 Sep 04;9:118
pubmed: 25185799
AIDS. 2016 Jul 31;30(12):1973-83
pubmed: 27149090
Infect Dis Obstet Gynecol. 2015;2015:276851
pubmed: 26823647
Health Serv Res. 2013 Dec;48(6 Pt 2):2134-56
pubmed: 24279835
PLoS Med. 2019 Sep 3;16(9):e1002885
pubmed: 31479452

Auteurs

Sarah Hicks (S)

Department of Epidemiology, University of Washington, Seattle, WA, USA. smd722@uw.edu.

Ben Odhiambo (B)

Kenyatta National Hospital, Nairobi, Kenya.

Felix Abuna (F)

Kenyatta National Hospital, Nairobi, Kenya.

Julia C Dettinger (JC)

Department of Global Health, University of Washington, Seattle, WA, USA.

Nancy Ngumbau (N)

Kenyatta National Hospital, Nairobi, Kenya.

Laurén Gómez (L)

Department of Epidemiology, University of Washington, Seattle, WA, USA.
Department of Global Health, University of Washington, Seattle, WA, USA.

Joseph Sila (J)

Kenyatta National Hospital, Nairobi, Kenya.

George Oketch (G)

Kenyatta National Hospital, Nairobi, Kenya.

Enock Sifuna (E)

Kenyatta National Hospital, Nairobi, Kenya.

Bryan J Weiner (BJ)

Department of Global Health, University of Washington, Seattle, WA, USA.
Department of Health Systems and Population Health, University of Washington, Seattle, WA, USA.

Grace John-Stewart (G)

Department of Epidemiology, University of Washington, Seattle, WA, USA.
Department of Global Health, University of Washington, Seattle, WA, USA.
Departments of Medicine, University of Washington, Seattle, WA, USA.
Departments of Pediatrics, University of Washington, Seattle, WA, USA.

John Kinuthia (J)

Kenyatta National Hospital, Nairobi, Kenya.

Anjuli D Wagner (AD)

Department of Global Health, University of Washington, Seattle, WA, USA.

Classifications MeSH